Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HOLISTA COLLTECH LIMITED Capital/Financing Update 2018

Jun 21, 2018

65044_rns_2018-06-21_aec079bc-cb62-4f41-ba89-b80fea0f9b5d.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [215 x 49] intentionally omitted <==

Holista CollTech Limited (ASX:HCT / ABN 24 094 515 992) 283 Rokeby Road Subiaco WA 6008 P: +61 8 6141 3500 ; F: +61 8 6141 3599 W: www.holistaco.com

ASX Announcement

22 June 2018

HOLISTA COLLTECH LIMITED SHARE PURCHASE PLAN

Holista Colltech Limited (Company) (ASX:HCT) is pleased to announce a Share Purchase Plan to raise up to $2,800,000, to be offered to eligible Shareholders at 7 cents per share ( SPP or Plan ). The Plan is partially underwritten by Managing Director, Dr Rajen Manicka, and Non-Executive Director, Mr Chan Heng Fai, subject to shareholder approval.

The SPP issue price is 7 cents per new share, which represents a 6.91% discount to the volume weighted average price of Shares over the last 15 trading days on which sales of shares were recorded on ASX prior to the date of the announcement of the SPP.

Purpose of capital raising

Funds raised under the Plan are to be used to fund marketing of the Company’s low GI noodle product in China and USA, and for product development.

Details of SPP

The SPP is only available to Australian, New Zealand and Singaporean shareholders who were registered as Company shareholders at 5 pm (WST) on Thursday, 21 June 2018 ( Eligible Shareholders ).

The SPP entitles Eligible Shareholders to purchase up to $15,000 of new ordinary shares in the Company at an issue price of 7 cents per new share free of brokerage and commissions. Participation in the Plan is entirely voluntary.

The SPP is capped at $2,800,000. The Plan is currently scheduled to close on 27 July 2018, however the Company reserves the right to close the Plan at any time.

Partial Underwriting

The SPP is partially underwritten by Dr Rajen Manicka and Mr Chan Heng Fai ( Underwriters ), subject to shareholder approval. Please note that the SPP is not conditional on the Underwriting being approved by shareholders.

Subject to receiving shareholder approval, the number of new shares that can be issued to Dr Manicka is a maximum of 25,386,270, subject to the percentage holding of Dr Manicka post-SPP being no greater than 43.16%, and the number of new shares that can be issued to Mr Chan is a maximum of 11,206,137, subject to the percentage holding of Mr Chan post-SPP being no greater than 24.53%.

A Notice of General Meeting seeking shareholder approval for the issue of new shares to the Underwriters will be despatched to shareholders at the same time as the SPP offer booklet. The General Meeting is scheduled to be held on 30 July 2018.

Full details of the SPP offer are contained in a booklet which is anticipated to be despatched to shareholders on 26 June 2018.

==> picture [145 x 33] intentionally omitted <==

Key Dates

The proposed timetable for the SPP is set out below. The Directors reserve the right to vary the dates and times without notice.

Record Date (5pm WST) 21 June 2018
The date on which the Company determined eligible
Announcement Date of Plan 22 June 2018
Opening DateandOffer Despatch Date 26 June 2018
Opening Date 26 June 2018
Closing Date (5pm WST). 27 July 2018
Issue Date 6 August 2018
Despatch of Holding Statements 7 August 2018

For further information, please contact:

Corporate Affairs & Business Opportunities

Dr Rajen Manicka: [email protected] General Enquiries: [email protected]

Australia

283 Rokeby Road Subiaco WA 6008 P: +61 8 6141 3500 ; F: +61 8 6141 3599

Malaysia

12th Floor, Amcorp Trade Centre, PJ Tower No. 18, Persiaran Barat off Jalan Timur 46000, Petaling Jaya, Malaysia P: +603 7965 2828 ; F: +603 7965 2777

Media and Investor Relations Enquiries

WeR1 Consultants Pte Ltd 3 Phillip Street #12-01 Singapore 048693 Asha Devi, [email protected]; P: + 603 2731 9244 Roshan Singh, [email protected]; P: +65 67374844

Brett Fraser Joint Company Secretary

==> picture [145 x 33] intentionally omitted <==

About Holista CollTech Ltd

Holista CollTech Ltd ( Holista ) is a research-driven biotech company and is the result of the merger of Holista Biotech Sdn Bhd and CollTech Australia Ltd. Headquartered in Perth with extensive operations in Malaysia, Holista is dedicated to delivering first-class natural ingredients and wellness products and leads in research on herbs and food ingredients.

Holista, listed on the Australia Securities Exchange, researches, develops, manufactures and markets “healthstyle” products to address the unmet and growing needs of natural medicine. Holista’s suite of ingredients is capable of serving the industry to provide low-GI baked products, low sodium salt, low fat fried foods and low calories sugar without compromise in taste, odour and mouth feel. It is the only company to produce sheep (ovine) collagen using patented extraction methods.